LON:SBTX SkinBioTherapeutics - SBTX Share Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding SkinBioTherapeutics Plc Please log in to your account or sign up in order to add this asset to your watchlist. GBX 20.75 -0.50 (-2.35%) (As of 02/3/2023 12:00 AM ET) Add Compare Share Share Today's Range 20.63▼ 21.9550-Day Range 15.16▼ 22.6352-Week Range 15▼ 54.40Volume407,932 shsAverage Volume390,391 shsMarket Capitalization£32.53 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsInsider TradesHeadlines About SkinBioTherapeutics (LON:SBTX) StockSkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health. It develops SkinBiotix technology that can enhance the formation of multi-protein complexes and prevent passage toxins, molecules, and ions, as well as pathogens; and AxisBiotix that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. The company has a collaboration agreement with Croda Plc; and the University of Manchester to develop bacterial lysates in the prevention of periodontal gun disease. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.Read More Receive SBTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SkinBioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address SBTX Stock News HeadlinesDecember 21, 2022 | marketwatch.comSkinBioTherapeutics Raises GBP2.6 Mln in Placing, Retail OfferDecember 15, 2022 | marketwatch.comSkinBioTherapeutics to Raise a Minimum of GBP2.5 MlnFebruary 5, 2023 | Tradewins (Ad)Know Your Profit Potential BEFORE You Trade!I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! October 14, 2022 | finance.yahoo.comAfter losing 68% in the past year, SkinBioTherapeutics Plc (LON:SBTX) institutional owners must be relieved by the recent gainAugust 31, 2022 | lse.co.ukSkinBioTherapeutics shares fall as probiotic AxisBiotix-PS sales dropAugust 31, 2022 | marketwatch.comSkinBioTherapeutics Shares Fall After Worse-Than-Expected Supplement SalesJune 15, 2022 | proactiveinvestors.comSkinBioTherapeutics puzzled by share price, says feedback positive for psoriasis treatmentJune 13, 2022 | marketwatch.comSkinBioTherapeutics Knows No Reason For Share Price FallFebruary 5, 2023 | Tradewins (Ad)Know Your Profit Potential BEFORE You Trade!I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! May 18, 2022 | finance.yahoo.comWe're Keeping An Eye On SkinBioTherapeutics' (LON:SBTX) Cash Burn RateMarch 29, 2022 | lse.co.ukSkinBioTherapeutics proposes Manprit Singh Randhawa as new CFOMarch 29, 2022 | marketwatch.comSkinBioTherapeutics Shares Drop 30% After Widened 1H Pretax LossFebruary 17, 2022 | finance.yahoo.comWhat Kind Of Shareholders Hold The Majority In SkinBioTherapeutics Plc's (LON:SBTX) Shares?January 19, 2022 | marketwatch.comSkinBioTherapeutics CFO to Step DownJanuary 18, 2022 | proactiveinvestors.comSkinBioTherapeutics seeks full-time finance chief and NED to guide social media strategyDecember 24, 2021 | markets.businessinsider.comSkinBioTherapeutics : Result of AGMDecember 4, 2021 | markets.businessinsider.comSkinBioTherapeutics : Notice of ResultsNovember 30, 2021 | marketwatch.comSkinBioTherapeutics Workflow Disrupted by Pandemic; Shares FallNovember 22, 2021 | markets.businessinsider.comSkinBioTherapeutics : Placing of SharesNovember 15, 2021 | marketwatch.comSkinBioTherapeutics Launches Discounted Share PlacingOctober 15, 2021 | markets.businessinsider.comSkinBioTherapeutics : AxisBiotix-PsT Psoriasis Food Supplement LaunchSeptember 2, 2021 | finance.yahoo.comWhat Type Of Shareholders Own The Most Number of SkinBioTherapeutics Plc (LON:SBTX) Shares?June 7, 2021 | markets.businessinsider.comSkinBioTherapeutics : Positive data for AxisBiotix-PsT consumer studyJune 6, 2021 | markets.businessinsider.comSkinBioTherapeutics : Holding(s) in CompanyMay 5, 2021 | sg.finance.yahoo.comSkinBioTherapeutics Plc (SBTX.L)March 29, 2021 | finance.yahoo.comHere's Why We're Not At All Concerned With SkinBioTherapeutics' (LON:SBTX) Cash Burn SituationMarch 21, 2021 | markets.businessinsider.comSkinBioTherapeutics : Exercise of WarrantSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SBTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SkinBioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address SBTX Company Calendar Last Earnings3/03/2020Today2/04/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:SBTX CUSIPN/A CIKN/A Webwww.skinbiotherapeutics.com Phone+44-161-4682760FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio3.07 Current Ratio11.19 Quick Ratio10.01 Sales & Book Value Annual Sales£21,949.00 Price / Sales1,482.16 Cash FlowGBX 2.31 per share Price / Cash Flow9.00 Book ValueGBX 2.70 per share Price / Book7.69Miscellaneous Outstanding Shares156,780,000Free FloatN/AMarket Cap£32.53 million OptionableNot Optionable BetaN/A Key ExecutivesMr. Stuart John Ashman (Age 56)CEO & Exec. Director Comp: $325.85kMr. Manprit Singh Randhawa (Age 39)CFO, Sec. & Director Comp: $177.98kDr. Catherine O'NeillChief Scientific Officer & Member of Scientific Advisory BoardKey CompetitorsCollagen Solutions plc (COS.L)LON:COSOndine BiomedicalLON:OBI4D pharmaLON:DDDDDestiny PharmaLON:DESTSynairgenLON:SNGView All Competitors SBTX Stock - Frequently Asked Questions How have SBTX shares performed in 2023? SkinBioTherapeutics' stock was trading at GBX 15.50 at the start of the year. Since then, SBTX shares have increased by 33.9% and is now trading at GBX 20.75. View the best growth stocks for 2023 here. How were SkinBioTherapeutics' earnings last quarter? SkinBioTherapeutics Plc (LON:SBTX) posted its earnings results on Tuesday, March, 3rd. The company reported ($0.64) earnings per share for the quarter. What other stocks do shareholders of SkinBioTherapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other SkinBioTherapeutics investors own include Avacta Group (AVCT), Inspired (INSE), OptiBiotix Health (OPTI), Lb-shell (LBP), Anglo African Oil & Gas (AAOG), Big Sofa Technologies Group (BST), Concepta PLC (CPT.L) (CPT), Fresnillo (FRES) and Shield Therapeutics (STX). What is SkinBioTherapeutics' stock symbol? SkinBioTherapeutics trades on the London Stock Exchange (LON) under the ticker symbol "SBTX." How do I buy shares of SkinBioTherapeutics? Shares of SBTX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is SkinBioTherapeutics' stock price today? One share of SBTX stock can currently be purchased for approximately GBX 20.75. How much money does SkinBioTherapeutics make? SkinBioTherapeutics (LON:SBTX) has a market capitalization of £32.53 million and generates £21,949.00 in revenue each year. How can I contact SkinBioTherapeutics? SkinBioTherapeutics' mailing address is 15 1 Silk House, Park Green, MACCLESFIELD, SK11 7QJ, United Kingdom. The official website for the company is www.skinbiotherapeutics.com. The company can be reached via phone at +44-161-4682760. This page (LON:SBTX) was last updated on 2/5/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.